Bridgebio Oncology Therapeutics, Inc. (BBOT)
1.86
+0.06
(+3.05%)
USD |
NASDAQ |
Nov 19, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Price : 1.86 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 1.81 | 1.99 | 1.81 | 1.86 | 366747.0 |
| Nov 18, 2026 | 1.91 | 1.96 | 1.79 | 1.805 | 576734.0 |
| Nov 17, 2026 | 2.00 | 2.09 | 1.92 | 1.94 | 375900.0 |
| Nov 16, 2026 | 2.13 | 2.226 | 1.97 | 1.98 | 801956.0 |
| Nov 13, 2026 | 2.37 | 2.37 | 2.11 | 2.14 | 677601.0 |
| Nov 12, 2026 | 2.50 | 2.68 | 2.00 | 2.35 | 779135.0 |
| Nov 11, 2026 | 2.33 | 2.65 | 2.25 | 2.56 | 1.424M |
| Nov 10, 2026 | 2.29 | 2.34 | 2.185 | 2.20 | 486866.0 |
| Nov 09, 2026 | 2.09 | 2.34 | 2.07 | 2.30 | 780844.0 |
| Nov 06, 2026 | 2.19 | 2.25 | 1.98 | 2.04 | 687045.0 |
| Nov 05, 2026 | 2.30 | 2.30 | 2.07 | 2.17 | 699093.0 |
| Nov 04, 2026 | 2.33 | 2.39 | 2.22 | 2.30 | 451527.0 |
| Nov 03, 2026 | 2.30 | 2.402 | 2.29 | 2.32 | 621266.0 |
| Nov 02, 2026 | 2.64 | 2.64 | 2.295 | 2.31 | 579583.0 |
| Oct 30, 2026 | 2.70 | 2.74 | 2.605 | 2.62 | 314785.0 |
| Oct 29, 2026 | 2.81 | 2.948 | 2.69 | 2.70 | 357038.0 |
| Oct 28, 2026 | 2.67 | 2.855 | 2.61 | 2.80 | 482218.0 |
| Oct 27, 2026 | 2.65 | 2.725 | 2.51 | 2.69 | 1.756M |
| Oct 26, 2026 | 2.66 | 2.68 | 2.61 | 2.64 | 483080.0 |
| Oct 23, 2026 | 2.83 | 2.83 | 2.60 | 2.66 | 737352.0 |
| Oct 22, 2026 | 2.66 | 2.85 | 2.66 | 2.85 | 661895.0 |
| Oct 21, 2026 | 2.71 | 2.855 | 2.66 | 2.68 | 942242.0 |
| Oct 20, 2026 | 2.85 | 2.98 | 2.70 | 2.72 | 660932.0 |
| Oct 19, 2026 | 2.84 | 2.90 | 2.79 | 2.85 | 695643.0 |
| Oct 16, 2026 | 2.95 | 2.95 | 2.81 | 2.82 | 480774.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Korsana Biosciences, Inc. | 35.45 |
| IRulya Therapeutics, Inc. | 39.94 |
| PepGen Inc. | 3.93 |
| Q32 Bio, Inc. | 8.48 |
| Oncolytics Biotech, Inc. | 0.3906 |
Price Related Metrics
| Price to Book Value | 0.5087 |
| Earnings Yield | -66.25K% |
| Market Cap | 149.24M |